These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25940040)

  • 1. Arrhenius activation energy of damage to catalase during spray-drying.
    Schaefer J; Lee G
    Int J Pharm; 2015 Jul; 489(1-2):124-30. PubMed ID: 25940040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-droplet evaporation kinetics and particle formation in an acoustic levitator. Part 2: drying kinetics and particle formation from microdroplets of aqueous mannitol, trehalose, or catalase.
    Schiffter H; Lee G
    J Pharm Sci; 2007 Sep; 96(9):2284-95. PubMed ID: 17523166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclone selection influences protein damage during drying in a mini spray-dryer.
    Bögelein J; Lee G
    Int J Pharm; 2010 Nov; 401(1-2):68-71. PubMed ID: 20887779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trehalose and sorbitol alter the kinetic pattern of inactivation of glutamate dehydrogenase during drying in levitated microdroplets.
    Lorenzen E; Lee G
    J Pharm Sci; 2013 Dec; 102(12):4268-73. PubMed ID: 24122651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Making large, flowable particles of protein or disaccharide in a mini-scale spray dryer.
    Schaefer J; Lee G
    Pharm Dev Technol; 2016 Nov; 21(7):803-811. PubMed ID: 26135384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of process variables on the powder yield of spray-dried trehalose on a laboratory spray-dryer.
    Maury M; Murphy K; Kumar S; Shi L; Lee G
    Eur J Pharm Biopharm; 2005 Apr; 59(3):565-73. PubMed ID: 15760738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designing CAF-adjuvanted dry powder vaccines: spray drying preserves the adjuvant activity of CAF01.
    Ingvarsson PT; Schmidt ST; Christensen D; Larsen NB; Hinrichs WL; Andersen P; Rantanen J; Nielsen HM; Yang M; Foged C
    J Control Release; 2013 May; 167(3):256-64. PubMed ID: 23415813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dextran or hydroxyethyl starch in spray-freeze-dried trehalose/mannitol microparticles intended as ballistic particulate carriers for proteins.
    Rochelle C; Lee G
    J Pharm Sci; 2007 Sep; 96(9):2296-309. PubMed ID: 17274046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spray-drying of proteins: effects of sorbitol and trehalose on aggregation and FT-IR amide I spectrum of an immunoglobulin G.
    Maury M; Murphy K; Kumar S; Mauerer A; Lee G
    Eur J Pharm Biopharm; 2005 Feb; 59(2):251-61. PubMed ID: 15661497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying critical process steps to protein stability during spray drying using a vibrating mesh or a two-fluid nozzle.
    Grasmeijer N; Tiraboschi V; Woerdenbag HJ; Frijlink HW; Hinrichs WLJ
    Eur J Pharm Sci; 2019 Feb; 128():152-157. PubMed ID: 30521944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of some water-miscible organic solvents for spray-drying enzymes and carbohydrates.
    Sass A; Lee G
    Drug Dev Ind Pharm; 2014 Jun; 40(6):749-57. PubMed ID: 23596974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of protein on mannitol polymorphic form produced during co-spray drying.
    Hulse WL; Forbes RT; Bonner MC; Getrost M
    Int J Pharm; 2009 Dec; 382(1-2):67-72. PubMed ID: 19682563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of spray dried submicron particles: Part A - Particle generation by aerosol conditioning.
    Strob R; Dobrowolski A; Schaldach G; Walzel P; Thommes M
    Int J Pharm; 2018 Sep; 548(1):423-430. PubMed ID: 29981411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of spray-drying conditions for the large-scale preparation of Bacillus thuringiensis var. israelensis after downstream processing.
    Prabakaran G; Hoti SL
    Biotechnol Bioeng; 2008 May; 100(1):103-7. PubMed ID: 18023058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Process design applied to optimise a directly compressible powder produced via a continuous manufacturing process.
    Gonnissen Y; Gonçalves SI; De Geest BG; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2008 Mar; 68(3):760-70. PubMed ID: 17964129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational analysis of protein secondary structure during spray-drying of antibody/mannitol formulations.
    Schüle S; Friess W; Bechtold-Peters K; Garidel P
    Eur J Pharm Biopharm; 2007 Jan; 65(1):1-9. PubMed ID: 17034996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality by design approach in the optimization of the spray-drying process.
    Baldinger A; Clerdent L; Rantanen J; Yang M; Grohganz H
    Pharm Dev Technol; 2012; 17(4):389-97. PubMed ID: 21275777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of operating and formulation variables on the morphology of spray-dried protein particles.
    Maa YF; Costantino HR; Nguyen PA; Hsu CC
    Pharm Dev Technol; 1997 Aug; 2(3):213-23. PubMed ID: 9552449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein powders for encapsulation: a comparison of spray-freeze drying and spray drying of darbepoetin alfa.
    Nguyen XC; Herberger JD; Burke PA
    Pharm Res; 2004 Mar; 21(3):507-14. PubMed ID: 15070103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of lysozyme on mannitol polymorphism in freeze-dried and spray-dried formulations depends on the selection of the drying process.
    Grohganz H; Lee YY; Rantanen J; Yang M
    Int J Pharm; 2013 Apr; 447(1-2):224-30. PubMed ID: 23500620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.